特发性炎症性肌病患者在三级转诊人群中计算机断层扫描用于癌症检测的诊断率
该单中心回顾性队列研究评估了特发性炎症性肌病(IIM)患者中胸部及腹盆部计算机断层扫描(CT)筛查/监测癌症的诊断率。IIM症状出现后3年内,胸部CT癌症检出率为0.9%(9/1011),腹盆部CT为1.8%(12/657);皮肌炎患者诊断率最高,抗转录中介因子1γ抗体阳性者胸部及腹盆部CT诊断率分别为2.9%和2.4%。抗合成酶综合征和免疫介导坏死性肌病假阳性率较高;作者认为按IIM亚型、自身抗体状态和年龄制定针对性癌症检测策略可能优化检出并减少过度筛查的危害与成本。
要点
- IIM症状出现后3年内,胸部CT癌症诊断率为0.9%(9/1011),腹盆部CT为1.8%(12/657)。
- 皮肌炎患者诊断率最高,抗转录中介因子1γ抗体阳性者胸部及腹盆部CT诊断率分别为2.9%和2.4%。
- 抗合成酶综合征胸部CT假阳性率4.4%、腹盆部CT假阳性率3.8%;免疫介导坏死性肌病胸部CT假阳性率4.4%。
核心结论
- 在三级转诊IIM队列中,CT成像对同期癌症的诊断率和假阳性频率范围较宽。
- 作者认为,根据IIM亚型、自身抗体阳性和年龄制定针对性的癌症检测策略,可能最大化癌症检出并最小化过度筛查的危害和成本。
研究设计与样本
- 单中心、回顾性队列研究,纳入特发性炎症性肌病(IIM)患者。
- 评估胸部CT和腹盆部CT的总体诊断率(诊断为癌症的数量/执行的检查数量)、假阳性百分比(未导致癌症诊断的活检数量/执行的检查数量)及检查特征。
主要发现
- IIM症状出现后3年内,胸部CT癌症诊断率为0.9%(9/1011),腹盆部CT为1.8%(12/657)。
- 皮肌炎患者胸部CT和腹盆部CT诊断率均最高,抗转录中介因子1γ抗体阳性者分别为2.9%和2.4%。
- 胸部CT假阳性率最高的为抗合成酶综合征(4.4%)和免疫介导坏死性肌病(4.4%),腹盆部CT假阳性率最高的为抗合成酶综合征(3.8%)。
- IIM发病年龄<40岁者胸部CT诊断率为0%、假阳性率为1.9%,腹盆部CT诊断率为0.5%、假阳性率为4.4%。
关键数值与推荐
- 胸部CT总体诊断率0.9%(9/1011),腹盆部CT总体诊断率1.8%(12/657),均为IIM症状出现后3年内。
- 皮肌炎患者胸部CT诊断率2.9%、腹盆部CT诊断率2.4%,为各亚型中最高。
- 抗合成酶综合征胸部CT假阳性率4.4%、腹盆部CT假阳性率3.8%;免疫介导坏死性肌病胸部CT假阳性率4.4%。
- IIM发病年龄<40岁者胸部CT诊断率0%、假阳性率1.9%;腹盆部CT诊断率0.5%、假阳性率4.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To inform guidance for cancer detection in patients with idiopathic inflammatory myopathy (IIM), we evaluated the diagnostic yield of computed tomography (CT) imaging for cancer screening/surveillance within distinct IIM subtypes and myositis-specific autoantibody strata. METHODS: We conducted a single-center, retrospective cohort study in IIM patients. Overall diagnostic yield (number of cancers diagnosed/number of tests performed), percentage of false positives (number of biopsies performed not leading to cancer diagnosis/number of tests performed), and test characteristics were determined on CT of the chest and abdomen/pelvis. RESULTS: Within the first 3 years since IIM symptom onset, a total of 9 of 1,011 (0.9%) chest CT scans and 12 of 657 (1.8%) abdomen/pelvis CT scans detected cancer. Diagnostic yields for both CT of the chest and CT of the abdomen/pelvis were highest in dermatomyositis, specifically anti-transcription intermediary factor 1γ (2.9% and 2.4% for CT of the chest and abdomen/pelvis, respectively). The highest percentage of false positives was in patients with antisynthetase syndrome (ASyS) (4.4%) and immune-mediated necrotizing myopathy (4.4%) on CT of the chest, and ASyS (3.8%) on CT of the abdomen/pelvis. Patients ages <40 years old at IIM onset had both low diagnostic yields (0% and 0.5%) and high false-positive rates (1.9% and 4.4%) for CT of the chest and abdomen/pelvis, respectively. CONCLUSION: In a tertiary referral cohort of IIM patients, CT imaging has a wide range of diagnostic yield and frequency of false positives for contemporaneous cancer. These findings suggest that cancer detection strategies targeted according to IIM subtype, autoantibody positivity, and age may maximize cancer detection while minimizing the harms and costs of over-screening.
引用
- Mecoli CA, Chee B, Chen M, et al. Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients. Arthritis Care Res (Hoboken). 2023. PMID: 36913182. doi:10.1002/acr.25114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。